Navigation Links
Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/13/2009

Conference call scheduled at 5:00 PM Eastern Time today

RICHMOND, Calif., May 13 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the quarter ended March 31, 2009.

Glenn A. Oclassen, President and Chief Executive Officer, commented "Intermezzo(R), our lead product candidate that is under review with the FDA, has the potential to be the first prescription sleep aid indicated for use in the middle of the night when patients awaken and have difficulty returning to sleep. Awakening in the middle of the night is a common sleep problem experienced by many Americans and a significant number have consulted their doctor for help. We are actively engaged in pre-commercial activities on behalf of Intermezzo(R), including discussions with marketing partner candidates in the United States and Europe, and we continue to make progress with our internal preparations for the potential product launch in the United States."

Intermezzo(R) Update

Intermezzo(R) Phase 3 clinical trials have been completed and, on September 30, 2008, Transcept submitted a new drug application (NDA) to the FDA, which was accepted for filing and assigned a Prescription Drug User Fee Act (PDUFA) date of July 30, 2009. As part of the NDA submission, Transcept requested that the FDA grant three years of Hatch-Waxman marketing exclusivity for Intermezzo(R). Transcept is also actively pursuing patents to cover Intermezzo(R) in the United States and key non-U.S. markets.

To maximize the value of Intermezzo(R), T
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
2. Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
3. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
4. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
5. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
6. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
7. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
8. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
11. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... babies conceived in spring, summer, when chemical concentrations peak ... increase the risk of birth defects, say researchers who ... U.S. babies occur among those conceived in the spring ... levels of pesticides in surface water. , Researchers analyzed ...
... My1Stop.com, the commercial printing superstore, launches the first in a series ... like those that will follow, provides customers with visual insights into ... ... Scott, KS (PRWEB) March 31, 2009 -- The laser membership cards ...
... and Aller-Ease® share some shocking information about what lurks beneath the sheets ... ... sanctuary - a safe haven for rest and rejuvenation. But if most ... lurking beneath the sheets, they might think that their bed is more ...
... March 31 JLL Partners, a leading private equity ... acquisition of PharmaNet Development Group, Inc. (Nasdaq: ... ("PharmaNet"). The acquisition was completed on March 30, ... Acquisition Corp. ("Purchaser"), with and into PharmaNet. As ...
... helps small corporations keep compliant with tedious record-keepingSEATTLE, ... of "Quick Corporate Minutes" desktop software that takes ... Now small-to-midsize "S" and "C" corporations can remain ... and for a fraction of the cost of ...
... SHANGHAI, March 31 /PRNewswire-Asia/ -- WuXi AppTec announced today ... the U.S. Food and,Drug Administration (FDA) without the issuance ... non compliance issues after a site inspection. , ... WuXi,s Bioanalytical Services (BAS) was ...
Cached Medicine News:Health News:Study Links Pesticides to Birth Defects 2Health News:My1Stop.com Launches Suite of Online Custom Printing Videos Beginning with Laser Membership Cards 2Health News:Five Secrets Your Bed Won't Tell You 2Health News:Five Secrets Your Bed Won't Tell You 3Health News:Five Secrets Your Bed Won't Tell You 4Health News:JLL Partners Announces Completion of Acquisition of PharmaNet 2Health News:Automate Corporate Minutes and Resolutions; Stop IRS Woes Before They Happen 2Health News:WuXi AppTec Bioanalytical Services Unit Passes FDA Inspection 2
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical ... J. Mark King as its new Chief ... of Chief Operating Officer, in which he has overseen ... , Mississippi , and Costa Rica.  ... years of broad-based operations, sales, engineering and manufacturing experience ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Insulin ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong ... systems especially for type 1 diabetes patients. ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ... fat content and preserved lean body mass following ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... STOUGHTON, Mass., Jan. 5, 2011 SyncMedical ... de Vigilancia Sanitaria – Brazilian National Health Surveillance Agency) ... System for sale in Brazil. SyncMedical,s Ethos Spine product ... and cost effective treatment solutions to surgeons in the ...
... (Nasdaq: HSKA ) today announced it will present ... LLC on Monday, January 10, 2011 at the Grand Hyatt ... Central) in New York City.  The presentation is scheduled to ... http://photos.prnewswire.com/prnh/20000622/HESKALOGO ) About Heska ...
Cached Medicine Technology:SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil 2
... Medtronic has been a key participant ... for more than a decade. Previous Medtronic ... for concentrated platelets, as well as to ... for producing platelet-rich plasma (PRP) for a ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
... Biliary Self-Expanding Stent System combines low-profile, high radial ... .018" guide wire compatible stent system provides 6F ... diameters (5.0 - 10.0 mm). Now, with longer ... in five stent lengths (28, 38, 56, 80 ...
... Supreme and Response catheters comprise ... catheters available for electrophysiology procedures. Their ... provide for superior torque response with ... multiple curves and French sizes, Supreme ...
Medicine Products: